NASDAQ Composite opens in less than one hour and Amgen’s pre-market value is already 2% down.
The last session, NASDAQ Composite finished with Amgen dropping 0.13% to $252.03. NASDAQ Composite slid 0% to $13,530.92, after three sequential sessions in a row of gains, on what was a somewhat positive trend trading session.
Amgen’s last close was $252.36, 5.13% under its 52-week high of $264.97.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s last day, last week, and last month’s average volatility was 1.65%, 1.30%, and 0.42%, respectively.
Amgen’s last day, last week, and last month’s high and low average amplitude percentage was 2.94%, 2.31%, and 2.12%, respectively.